Compass Pharma Services has completed a capital investment project to upgrade its production capabilities to include ISO Class 8 (ISO 14644) specifications in order to provide packaging services for certain high-potency pharmaceutical products.
“These capital improvements now allow us to provide cGMP contract packaging services for select potent pharmaceutical compounds such as enzymes, antibiotics, antifolates, antimetabolites and some hormones,” said Tony Fenno, chief operating officer. “Compass Pharma investments continue to position the company as a responsive contract pharmaceutical packaging partner for sophisticated, high-demand contract packaging services for the pharmaceutical industry.”
The improvements for ISO-Class 8 certification include a fully integrated production suite where the primary packaging area has negative differential air pressure relative to surrounding gowning and secondary packaging areas. High-Efficiency Particulate Air (HEPA) filters are used in the primary packaging area.
Manufacturing Automation Corp. of Princeton, NJ assisted with the engineering/design and validation of the new ISO Class 8 area. Also, Whitehouse Analytical Laboratories, Inc. has been retained to provide the company with ongoing analytical services.
Sign up today for Contracting & Outsourcing 2009!